Related Experiment Video

Updated: Aug 18, 2026

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
08:30

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures

Published on: July 9, 2012

Ampicillin resistance in Haemophilus influenzae as determined by a rapid test for beta-lactamase production

C Thornsberry, L A Kirven

    Antimicrobial Agents and Chemotherapy
    |November 1, 1974
    PubMed

    Abstract:

    A rapid capillary tube method was used to demonstrate beta-lactamase production by ampicillin-resistant strains of Haemophilus influenzae.

    More Related Videos

    Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
    14:04

    Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

    Published on: May 8, 2013

    Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
    06:40

    Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance

    Published on: July 28, 2023

    Related Experiment Videos

    Last Updated: Aug 18, 2026

    One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
    08:30

    One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures

    Published on: July 9, 2012

    Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
    14:04

    Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

    Published on: May 8, 2013

    Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
    06:40

    Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance

    Published on: July 28, 2023

    Related Concept Videos

    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...

    Articles linked to this work by shared authors, journal, and citation graph.

    Key ^{19}Ne States Identified Affecting γ-Ray Emission from ^{18}F in Novae.

    Physical review letters·2019

    Susceptibility tests for sulfamethoxazole-trimethoprim by a broth microdilution procedure.

    Current microbiology·2013

    Evaluating the in vitro susceptibility of bovine mastitis pathogens to a combination of kanamycin and cefalexin: Recommendations for a disk diffusion test.

    Journal of dairy science·2009

    Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.

    The Journal of antimicrobial chemotherapy·2009

    Development of a standardized susceptibility test for campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem.

    Microbial drug resistance (Larchmont, N.Y.)·2004

    Antimicrobial susceptibility to levofloxacin and other antibacterial agents among common respiratory pathogens-a Brazilian perspective from the GLOBAL Surveillance Initiative 2001-2002.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2004

    Dermatophytes in Argentina: species distribution, comparative identification accuracy of conventional and proteomic methods, introduction of a novel molecular identification approach, and antifungal susceptibility profiles.

    Antimicrobial agents and chemotherapy·2026

    OT-CATH, a conserved antimicrobial peptide in Otariidae species, exhibits potent activity against gram-negative bacteria.

    Antimicrobial agents and chemotherapy·2026

    Pulmonary pharmacokinetics and lesion penetration of antimicrobials in patients with nontuberculous mycobacterial disease.

    Antimicrobial agents and chemotherapy·2026

    G-quadruplex-binding ligand RHPS4 reduces Plasmodium falciparum mitochondrial DNA level providing a novel antimalarial strategy.

    Antimicrobial agents and chemotherapy·2026

    Relative inhibitory activities of taniborbactam and xeruborbactam against KPC variants conferring reduced susceptibility or resistance to ceftazidime/avibactam, cefiderocol, and cefepime/taniborbactam.

    Antimicrobial agents and chemotherapy·2026

    Anti-plasmodial activity of proteasome inhibitors against various Plasmodium species: a preclinical evaluation.

    Antimicrobial agents and chemotherapy·2026

    Single-Cell Membrane-Permeabilization Kinetics Reveal Species-Specific Responses to Antimicrobial Photodynamic Treatment.

    ACS omega·2026

    Hospital-Based Surveillance of Antimicrobial Resistance in Southern Brazil: Resistance Profiles and Phenotypic Carbapenemase Screening.

    Indian journal of medical microbiology·2026

    Antimicrobial resistance profiles and genomic diversity of vaginal Prevotella bivia isolates from South African women, including the first report of nimK in South African vaginal P. bivia isolates.

    Anaerobe·2026

    First reported human Castellaniella defragrans bacteraemia: a case report.

    Swiss medical weekly·2026

    Antibacterial activity of seawater-derived Bacillus subtilis strain SC2 and its bioactive fraction.

    Archives of microbiology·2026

    Highly- and Low-virulent Mycobacterium tuberculosis Strains of the Beijing Genotype Elicit Contrasting Immune Response in C57BL/6 Mice as Revealed by Inducible Nitric Oxide Synthase and Tumor Necrosis Factor-alpha Distinct Expression.

    International journal of mycobacteriology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us